Growth Trends in the Cell and Gene Therapy Manufacturing Market

The global cell and gene therapy manufacturing market was valued at approximately USD 3.76 billion in 2022 and is projected to grow to around USD 13.60 billion by 2032, reflecting a compound annual growth rate (CAGR) of 16.25% from 2023 to 2032.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5024

Cell and gene therapy has generated significant interest due to its potential to treat cancer. As this complex and rapidly growing industry expands, Contract Development and Manufacturing Organizations (CDMOs) are playing a key role in helping businesses streamline the manufacturing process for these therapies.

In August 2022, Cytiva, a subsidiary of Danaher Corporation, partnered with Forecyte Bio, a CDMO specializing in cell and gene therapy, to accelerate the development and production of these therapies in both China and the U.S. Through this collaboration, Forecyte Bio will leverage Cytiva’s Flex Factory platform to launch and expand its CDMO services.

Leading Companies in the Cell and Gene Therapy Manufacturing Market

1. Bluebird Bio Inc.
   A pioneer in gene therapy, Bluebird Bio focuses on developing innovative therapies for genetic diseases and cancer. The company’s expertise lies in the manufacturing of cell and gene therapies, helping to advance treatments with high unmet needs.
2. Hitachi Chemical Co., Ltd.
   Now known as Showa Denko Materials, Hitachi Chemical is involved in the development and production of advanced biopharmaceutical products, including cell and gene therapies, offering solutions for various stages of therapy manufacturing.
3. Takara Bio Inc.
   Takara Bio specializes in biotechnology, providing a wide range of services from gene therapy development to production. Their advanced manufacturing platforms support the commercialization of cell-based therapies.
4. Catalent Inc.
   Catalent is a leading provider of advanced delivery technologies, development services, and manufacturing solutions for biologics. The company plays a critical role in cell and gene therapy production through its robust platform offerings.
5. F. Hoffmann-La Roche Ltd.
   Roche is a global leader in healthcare, with a strong focus on personalized treatments, including cell and gene therapies. The company is deeply invested in advancing these therapies to address serious medical conditions such as cancer and genetic disorders.
6. Samsung Biologics
   A major player in the biopharmaceutical manufacturing industry, Samsung Biologics provides comprehensive contract manufacturing services for cell and gene therapies. Its state-of-the-art facilities and expertise support the growth of advanced biologic therapies.
7. Novartis AG
   Novartis is at the forefront of gene therapy innovation, with its well-known therapies like Kymriah. The company focuses on bringing advanced gene and cell therapies from development to commercial production, aiming to transform patient care.
8. Lonza
   Lonza is a global leader in the biopharmaceutical manufacturing sector, offering contract services for cell and gene therapy development. The company’s capabilities are key to the production of complex, personalized medicine.
9. Merck KGaA
   Merck KGaA, Darmstadt, Germany, is a science and technology company heavily invested in cell and gene therapy. The company provides technologies and services that aid in the development, manufacturing, and commercialization of these innovative therapies.
10. Wuxi Advanced Therapies
    Wuxi Advanced Therapies is known for its contract development and manufacturing services for cell and gene therapies. The company offers end-to-end solutions from research and development to commercial-scale production.
11. Boehringer Ingelheim
    Boehringer Ingelheim provides contract manufacturing services and solutions for gene therapy, offering a wide range of capabilities to bring cell and gene-based treatments to the market.
12. Cellular Therapeutics
    Cellular Therapeutics specializes in the production of cell-based therapies, with a focus on offering innovative solutions to support clinical and commercial-scale manufacturing of cell and gene therapies.
13. Miltenyi Biotec
    Miltenyi Biotec provides cutting-edge technologies for cell and gene therapy manufacturing, from cell processing to final therapy production. The company’s products and services are designed to advance the field of cellular medicine.
14. Thermo Fisher Scientific
    Thermo Fisher Scientific plays a pivotal role in the development and manufacturing of gene and cell therapies. The company offers comprehensive solutions to support every phase of the production process, from discovery to commercial-scale manufacturing.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/cell-and-gene-therapy-manufacturing-market-experiencing-significant-growth

Access exclusive insight now @ https://www.towardshealthcare.com/price/5024

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare